CERS News and Press, Cerus Corporation From 05/03/22

Cerus (NASDAQ:CERS) on Tuesday signed a ten-year agreement with Germany's Fresenius Kabi for the production of INTERCEPT Blood System sets. Tuesday's new contract replaces the current one with Fresenius Kabi that was set to expire in July 2025. Fresenius Kabi will continue producing sets for ...

10-Year Collaboration Will Support Growing Global Demand for the INTERCEPT Blood System and Help Expand Access to Pathogen-Reduced Blood Components to Patients Cerus Corporation (Nasdaq: CERS) today announced that it has signed a ten-year agreement with Fresenius Kabi for th...

Cerus (NASDAQ:CERS) said it signed a five-year contract with the American Red Cross for the Intercept Blood System for platelets. Under the agreement, Cerus (CERS) will continue to supply the Red Cross the Intercept Blood System used to produce pathogen reduced platelets, in support of t...

5-year Agreement Strengthens Cerus’ Leadership Position in the U.S. Market and Will Expand Patient Access to INTERCEPT Platelets Cerus Corporation (Nasdaq: CERS) today announced that it has signed a five-year contract with the American Red Cross for the INTERCEPT Bloo...

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2022 financial results will be released on Thursday, May 5, 2022, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will...

Cerus Corporation (NASDAQ:CERS) traded today at a new 52-week high of $8.98. This new high was reached on above average trading volume as 141.1 million shares traded hands, while the average 30-day volume is approximately 1.5 million shares. In the past 52 weeks, Cerus Corporation share ...

Baker Brothers’ 13F portfolio value decreased from $22.77B to $20.55B this quarter. Incyte and Legend Biotech stakes were increased this quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~63% of the portfolio. For f...

Gainers: Semtech Corporation (NASDAQ:SMTC) +4%. Forterra (NASDAQ:FRTA) +4%. Cerus Corporation (NASDAQ:CERS) +4%. Inspirato Incorporated (NASDAQ:ISPO) +4%. Infinera Corporation (NASDAQ:INFN) +4%. Losers: Codex DNA (NASDAQ:DNAY) -6%. CureVac  (NASDAQ:CVAC) -5%. CarParts...

The Ark Innovation ETF was fallen 60% from its high water mark, far more than 10%ish drop of the handful of growth stocks which top the S&P 500 and NASDAQ100. Charts and tables for price and AUM show clearly the the majority of investors in ARKK bought at the top; most ARKK holder...

Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ chief financial officer, is scheduled to participate at the Cowen 42 nd Annual Health Care Conference on Wednesday, March 9, 2022 at 1:30 p.m. EST. A live webcast of the event will be available o...